Turning Point Brands Inc Dossier - Source-backed chat

Turning Point Brands Inc

TPBNYSE

SectorConsumer Staples

IndustryTobacco

Beta (adjusted)0.95

Intrinsic Value $37.92median of 6 methods · middle span $18-$45based on filings through 30 Jun 2026

Market Price $58.70Price as of 30 Sep 2026

OvervaluedIntrinsic value is 35% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $1.2B

Enterprise Value $1.2B

Shares Outstanding 20.3M diluted

Moat Rating Wide

Next Earnings Date4 Nov 2026

Last ex-dividend18 Sep 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Turning Point Brands is undergoing a powerful structural transformation driven by its high-growth Modern Oral nicotine pouch segment (FRE and ALP). While legacy segments like Zig-Zag face temporary headwinds from distribution transitions, the explosive triple-digit growth in modern oral products is rapidly shifting the company's revenue mix toward higher-margin categories. The market is currently underpricing this transition, presenting a compelling entry point as the company onshores production to unlock significant margin expansion.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets6 analysts · as of 18 Aug 2026

Low · most bearish analyst$115.00

Mean target$125.17

High · most bullish analyst$140.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$75.0015%

Regulatory hurdles or FDA marketing denial orders disrupt the Modern Oral expansion. Onshoring delays prevent margin expansion, while the Zig-Zag segment continues to decline due to intense competition in rolling papers and wraps.

Base CaseCentral scenario

$125.1760%

Matches the consensus mean

Modern Oral net sales meet the raised FY 2026 guidance of $211M-$225M, supported by steady retail expansion. Onshoring of pouch production begins to yield margin benefits in late 2026, offsetting moderate near-term weakness in Zig-Zag papers and wraps.

Bull CaseUpside scenario

$140.0025%

Modern Oral products achieve rapid national retail distribution expansion (exceeding the 70% chain store count target) and production onshoring at the Louisville facility occurs ahead of schedule, driving segment gross margins toward 70%. Zig-Zag stabilizes quickly following the Clipper transition.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Explosive growth in the Modern Oral segment, which grew 133% YoY in Q1 2026 to represent 42% of total net sales.
Substantial margin expansion potential from onshoring modern oral production to the Louisville facility.
Strong liquidity profile with $192.4 million in cash as of Q1 2026.

Key Investment Risks

Regulatory risks associated with FDA PMTA approvals for nicotine pouch products.
Near-term revenue pressure in the Zig-Zag segment due to weaker U.S. papers and wraps shipments.
Increased SG&A expenses from elevated sales and marketing investments to support brand building.

Thesis Invalidation Triggers

FDA issuance of final Marketing Denial Orders for FRE or ALP nicotine pouches.
Modern Oral net sales falling significantly below the guided FY 2026 range of $210-$225 million.
Failure to achieve gross margin expansion in the modern oral segment due to persistent manufacturing inefficiencies.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.